Sign in
4

Changes in Ownership

Prime Medicine, Inc. Filed Acc 0001894562-23-000004

Options or other derivatives

  • Chief Business Officer acquired 135,747 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Brudnick Richard Chief Business Officer 2023-03-31 Grant or award · Stock Option (right to buy) +135,747 135,747 D
Loading xslF345X04/wf-form4_168065416536123.xml…